Publication Name	World Journal of Nephrology
Manuscript ID	12014
Country	Türkiye

Received	2014-06-17 20:23
Peer-Review Started	2014-06-18 08:52
To Make the First Decision	2014-08-14 15:02
Return for Revision	2014-08-19 13:30
Revised	2014-09-03 14:25
Second Decision	2014-10-10 18:00
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-10-10 18:12
Articles in Press	2014-10-10 18:12
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-10-14 04:24
Typeset the Manuscript	2015-01-10 18:16
Publish the Manuscript Online	2015-02-07 09:38

ISSN	2220-6124 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Minireviews
Article Title	Role of β2-microglobulin in uremic patients may be greater than originally suspected
Manuscript Source	Invited Manuscript
All Author List	Aysegul Zumrutdal
Funding Agency and Grant Number
Corresponding Author	Aysegul Zumrutdal, MD, Professor, Nephrology Department, Baskent University Adana Teaching and Research Center, Baskent University Hospital, Yuregir, Dadaloglu Mah, 2591 St, 4/A, Adana 01230, Turkey. azumrutdal@yahoo.com
Key Words	Beta2-microglobulin; Carotid atherosclerosis; Cardiovascular disease; Cardiovascular risk; Coronary artery disease; Hemodialysis; Mortality; Uremia; Uremic toxins
Core Tip	Previously, the clinical significance of beta2-microglobulin (β2M) in uremic patients was limited to β2M-derived amyloidosis; in recent years, its role and power has changed and expanded. Although there have been some inconsistencies among the various analyses relating to β2M, the data generally support β2M as a promising novel marker of kidney function by predicting cardiovascular (CV) risk, CV events and overall mortality.
Publish Date	2015-02-07 09:38
Citation	Zumrutdal A. Role of β2-microglobulin in uremic patients may be greater than originally suspected. World J Nephrol 2015; 4(1): 98-104
URL	http://www.wjgnet.com/2220-6124/full/v4/i1/98.htm
DOI	http://dx.doi.org/10.5527/wjn.v4.i1.98

Full Article (PDF)	WJN-4-98.pdf
Full Article (Word)	WJN-4-98.doc
Manuscript File	12014-Review.docx
Answering Reviewers	12014-Answering reviewers.pdf
Copyright License Agreement	12014-Copyright aasignment.pdf
Peer-review Report	12014-Peer review(s).pdf
Scientific Misconduct Check	12014-CrossCheck.jpg
Scientific Editor Work List	12014-Scientific editor work list.pdf